A chromatogram is the most informative document a research peptide supplier can hand you, and it is also the one most often glanced at rather than read. If you are qualifying material for an assay, ten minutes spent on the trace itself is worth more than an hour spent on the marketing page around it.
What the axes are telling you
In reverse-phase HPLC the x-axis is retention time and the y-axis is detector response, almost always UV absorbance. Peptides are detected at 214 nm, where the amide bond of the peptide backbone absorbs, or at 280 nm, where aromatic residues absorb. The wavelength matters: a peptide with no tryptophan, tyrosine or phenylalanine barely registers at 280 nm, so a trace run only at that wavelength can look deceptively clean.
Retention time on its own is not an identity. It is a property of the method — the column chemistry, the gradient, the flow rate, the temperature and the mobile phase — and the same compound will elute at a different time on a different system. Retention time confirms consistency between runs on one method. It does not confirm what the molecule is.
The main peak, and the number attached to it
The purity figure quoted for a peptide is almost always area percent: the area under the main peak divided by the total integrated area of all peaks, expressed as a percentage. It is a relative measurement, and it carries three assumptions worth naming.
First, it assumes everything present absorbs at the detection wavelength. Anything that does not absorb — residual salts, some scavengers, water, counter-ions — is invisible to the detector and therefore absent from the denominator. Second, it assumes equal response factors, which is not strictly true across different impurities. Third, it assumes everything eluted; material that stayed on the column never enters the calculation at all.
None of that makes area percent useless. It makes it a statement about the chromatographic profile rather than a statement about mass. That distinction is the subject of its own discussion, and it is the single most common source of confusion when a laboratory calculates concentration from a vial.
What to look at besides the tall peak
Baseline behaviour. A drifting or noisy baseline makes integration boundaries arbitrary, and arbitrary boundaries move the purity number. A flat, quiet baseline is a sign of a method that was set up properly.
Peak shape. Symmetry matters. Tailing suggests secondary interactions with the stationary phase; fronting often means the column was overloaded. An overloaded peak can swallow small impurities eluting close to it, which flatters the purity figure.
Shoulders and near-eluting peaks. The impurities that matter most in peptide synthesis are structurally similar to the target — deletion sequences missing a residue, incompletely deprotected material, oxidised variants. Structural similarity means chromatographic similarity, so those are exactly the peaks that hide in the shoulder of the main one. A trace with visible separation around the main peak is more informative than one where everything is fused into a single mass.
The gradient window. A steep gradient run quickly will compress everything into a narrow band and produce a flattering number. A shallower gradient across a longer run separates more and usually reveals more. If a method is disclosed, look at how much time the peptide actually spends being separated.
What a chromatogram cannot tell you
It cannot tell you the compound is the compound. Retention time is consistent with an identity; it does not establish one. Confirmation of identity comes from mass spectrometry, where the measured mass is compared against the calculated mass of the intended sequence. A purity trace without a mass confirmation tells you that a sample is chromatographically homogeneous, not that it is homogeneously the right thing.
It also cannot tell you about anything that does not absorb UV light, does not elute, or was never injected. Endotoxin, residual solvent, water content and counter-ion content are all outside its reach and require their own methods.
How this shapes what we publish
Each product in our catalogue is analysed by an independent laboratory using reverse-phase HPLC, and the result is published on the product page so it can be read before an order rather than requested after one. Our vials carry no batch or lot number: a vial is matched to its published test by crimp and cap colour, and we would rather state that plainly than describe documentation we do not issue.
If you want to interrogate a figure we have published, that is the correct instinct, and our purity reimbursement commitment exists precisely for laboratories that act on it. Send a vial to a laboratory of your choosing; if the result comes back below the published figure for that product, we refund the purchase price and the cost of your test, subject to the eligibility requirements in our Refund Policy.
Research use only. All products supplied by Battle Born Peptides are laboratory reference materials for in-vitro research and analytical use by qualified professionals. They are not drugs, foods, dietary supplements, cosmetics or medical devices; they are not approved by the FDA or any other regulator for use in humans or animals; and they are not intended to diagnose, treat, cure, mitigate or prevent any disease, or to affect the structure or any function of the body of humans or animals. Nothing in this article is preparation, handling or dosing guidance. See our full research-use terms.
Leave a comment